Omeprazole treatment of severe peptic disease associated with antral G cell hyperfunction and hyperpepsinogenemia I in an infant (Q68613260)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

title

Omeprazole treatment of severe peptic disease associated with antral G cell hyperfunction and hyperpepsinogenemia I in an infant (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference

C De Giacomo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

R Fiocca

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

L Villani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

G Licardi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

M S Scotta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

E Solcia

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

language of work or name

English

0 references

publication date

1 December 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Pediatrics

25 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

page(s)

989-993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

Zollinger-Ellison Syndrome: Current Concepts and Management

25 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Pseudo-Zollinger--Ellison syndrome in a child presenting with anemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Family Studies of Hypergastrinemic, Hyperpepsinogenemic I Duodenal Ulcer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Omeprazole in Zollinger-Ellison syndrome. Effects of a single dose and of long-term treatment in patients resistant to histamine H2-receptor antagonists.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Histopathological classification of nonantral gastric endocrine growths in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Basal and pentagastrin-stimulated gastric acid secretory rates in normal children and in those with peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Pseudo-Zollinger-Ellison syndrome: hypergastrinemia, hyperchlorhydria without tumor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+) ATPase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Long-Term Omeprazole Treatment in Man: Effects on Gastric Endocrine Cell Populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Gastric argyrophil carcinoidosis in patients with Zollinger-Ellison syndrome due to type 1 multiple endocrine neoplasia. A newly recognized association.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

Long-term efficacy and safety of omeprazole in patients with Zollinger-Ellison syndrome: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980152-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-3476(05)80152-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2246706%20AND%20SRC:MED&resulttype=core&format=json

25 September 2019

1 reference